Whether you operate a single-location dermatology practice or a multi-site medical spa group, Cynosure clinical applications teams help match platform capabilities to your patient demographics, treatment mix, and business model.
Board-certified dermatologists require laser platforms that address a wide range of clinical indications from a single investment. The Elite iQ dual-wavelength system covers hair reduction, pigmented and vascular lesion treatment, and skin revitalization from one platform — reducing capital outlay and footprint compared to maintaining separate single-indication devices.
For practices that also offer tattoo removal, adding PicoSure Pro provides a picosecond capability that handles resistant ink colors and post-tattoo pigmentary changes that nanosecond systems cannot address efficiently. The published evidence base for both platforms allows dermatologists to present treatment recommendations backed by peer-reviewed data rather than device manufacturer marketing alone.
Medical spa operations compete on treatment outcomes, patient experience, and throughput efficiency. The Vectus diode laser's 23x38mm spot size treats a full back in approximately 15 minutes — compared to 30-45 minutes on smaller-spot systems. That throughput difference represents 2-3 additional patient slots per treatment room per day.
PicoSure skin revitalization using the Focus Lens Array provides a "lunchtime" procedure — minimal downtime treatments that generate recurring patient visits. Published data shows visible improvement in skin texture after 3-4 sessions at 4-6 week intervals. This treatment cadence generates predictable recurring revenue. We provide business modeling tools that project ROI based on your local market pricing and expected treatment volume.
Plastic surgery practices increasingly offer non-invasive aesthetic treatments as complements to surgical procedures and as standalone revenue services for patients who are not surgical candidates. Cynosure laser platforms serve both roles: pre-surgical skin preparation, post-surgical scar revision, and independent aesthetic services including body contouring and skin tightening.
The 1060nm diode body contouring platform provides non-invasive fat reduction that fills a clinical gap between lifestyle modification and surgical liposuction. Published clinical data shows measurable reduction in subcutaneous adipose tissue at 12-week post-treatment measurement. This technology should be presented to patients as a complement to — not a replacement for — surgical body contouring when significant volume reduction is the goal. Our clinical team can help position these services appropriately within your surgical practice's treatment menu.
Our medical applications team evaluates your patient demographics, current treatment offerings, competitive landscape, and growth objectives to recommend a platform configuration. The consultation is complimentary and obligation-free.